The five-year survival for women with Stage I borderline tumors is about 95% to 97%, but because of late recurrence the 10-year survival is only 70% to 95%. The five-year survival for Stage II-III patients is 65% to 87%. A more correct staging procedure, classification of true serous implants, and a
Tumor markers in inclusion cysts of the ovary
β Scribed by Ancel Blaustein; Alexander Kaganowicz; Janet Wells
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 451 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The clinical course of adult granulosa cell tumor of the ovary is characterized by indolent growth tending toward late recurrence. a variety of clinical and pathologic parameters have previously been evaluated for prognostication with inconclusive results. ## Methods: The clinical
BACKGROUND. β£-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH) closely follow the course of germ cell tumors (GCTs) and are widely used for diagnosis, prognosis, and follow-up purposes. The objective of this study was to assess the concordance of tumor markers a
## BACKGROUND. The authors conducted this study to update their experience with patients who have ovarian serous borderline tumors with noninvasive peritoneal implants, with the objectives of gaining additional insight into the biologic behavior of these tumors and understanding better the effects
We sought to determine the maternal serum levels of four tumor-associated antigens during the three trimesters of pregnancy in healthy women. CEA, CA 228, CA 15-3, and Her2/neu oncogene product p105 assay values were determined for 90 healthy pregnant women during the three trimesters of pregnancy a